Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Applied DNA Sciences Inc    

APPLIED DNA SCIENCES INC
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Applied DNA Sciences Inc : Applied DNA Sciences Continues Expansion in Sweden

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/11/2012 | 04:40am CEST
Applied DNA Sciences Continues Expansion in Sweden Security Giant Nokas Adopts DNA Evidentiary Marking

MEDIA CONTACT: Mitchell Miller, 646-543-3373, fax: 631-444-8848

INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848

FCMN Contact: [email protected]

PROGRAM CONTACT: Leif Svensson, CEO, Safe Solution AB, +46 76-774 44 14

Web site: http://www.adnas.com

Twitter: @APDN, @APDNInvestor

STONY BROOK, NY, December 10, 2012. Applied DNA Sciences, Inc. (OTC Bulletin Board: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that its evidentiary DNA platform has been adopted in Sweden for use in helping protect cash in transit in that country. The security company Nokas AS revealed that APDN's marking and authentication

platform will first be deployed in armored vehicles in the Stockholm area and then expanded to the company's
entire fleet.
The technology comes into play during a robbery, when botanically-based DNA marks within a water-based spray are released on cash notes and the criminals themselves. The marks can survive on the notes, clothes, and skin for long periods of time. In court, they provide accepted evidence directly linking criminals to the crime.
Nokas, based in Norway, fields a fleet of over 250 armored trucks to transport cash. It is one of only two cash transport companies in Sweden servicing many retail chains, large banks and other institutions.
The APDN platform for cash in transit already has been used with great success in the United Kingdom, where DNA evidence has helped in over fifty convictions of armed and dangerous criminals since 2009, in an environment where front-line police and private guards are typically unarmed. The DNA marking and authentication platform protects more than 26% of cash being transported to and from banks in the United Kingdom.
Johan Petersson, Nokas security officer, commented, "This is an exciting development for the entire security industry. We are the first with new technology in cash in transit in this region, which helps deter crime and helps the judiciary to prosecute any offense. Using this new technology, Nokas will provide added security to its staff and customers. We believe we are at the forefront."
Elsewhere in Sweden, adoption of the APDN DNA platform has been expanding.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on APPLIED DNA SCIENCES INC
04/19APPLIED DNA SCIENCES : to Debut Security Print Platform Solution Featuring Video..
AQ
04/11APPLIED DNA SCIENCES : to Debut Security Print Platform Solution Featuring Video..
AQ
04/10APPLIED DNA SCIENCES : to Debut Security Print Platform Solution Featuring Video..
BU
04/05APPLIED DNA SCIENCES, INC. (NASDAQ : APDN) Files An 8-K Regulation FD Disclosure
AQ
04/05APPLIED DNA SCIENCES INC : Entry into a Material Definitive Agreement, Financial..
AQ
04/05APPLIED DNA SCIENCES : Signs Definitive Agreements with Colorcon for Molecular T..
BU
03/27APPLIED DNA SCIENCES INC : Blog Exposure - Applied DNA Fulfills Rosier’s Order f..
AC
03/23APPLIED DNA SCIENCES : and Rosier Deliver SigNature®-Tagged Fertilizer to Turkey..
BU
03/22GHCL : Unveils recycled pet-based bedding
AQ
03/20APPLIED DNA SCIENCES : GHCL Launches “Rekoop” Featuring Applied DNA&..
BU
More news
Financials ($)
Sales 2018 9,05 M
EBIT 2018 -8,80 M
Net income 2018 -8,83 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 4,89x
Capi. / Sales 2019 2,80x
Capitalization 44,3 M
Chart APPLIED DNA SCIENCES INC
Duration : Period :
Applied DNA Sciences Inc Technical Analysis Chart | US03815U1025 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 5,00 $
Spread / Average Target 247%
EPS Revisions
Managers
NameTitle
James A. Hayward Chairman, President & Chief Executive Officer
Beth Jantzen Chief Financial Officer & Controller
Judith Murrah Secretary & Chief Information Officer
Sanford R. Simon Independent Director
Yacov A. Shamash Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APPLIED DNA SCIENCES INC44
ECOLAB10.71%43 206
SIKA-4.07%16 740
SYMRISE-6.34%10 720
INDORAMA VENTURES PCL--.--%10 308
JOHNSON MATTHEY PLC6.18%8 958